A detailed history of Aquatic Capital Management LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 12,500 shares of AQST stock, worth $38,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,500
Previous 8,100 54.32%
Holding current value
$38,125
Previous $21,000 195.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.4 - $5.09 $10,560 - $22,396
4,400 Added 54.32%
12,500 $62,000
Q2 2024

Aug 14, 2024

BUY
$2.31 - $4.5 $18,711 - $36,450
8,100 New
8,100 $21,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $163M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.